US EditionJury orders Abbott to pay $53 million in preterm infant formula trial, media report says
Jurors are weighing $52 million in damages after plaintiffs said Abbott’s preterm formula caused necrotizing enterocolitis in four babies.
- A jury in Chicago ordered Abbott Laboratories to pay $53 million in compensatory damages to families whose premature infants developed a potentially fatal bowel disease after consuming Abbott's cow's milk-based formula.
- Nearly 1,000 lawsuits have been filed against Abbott and Mead Johnson alleging their preterm infant formulas cause necrotizing enterocolitis , which kills bowel tissue and has over 20% mortality rate.
- While companies claim their formulas are essential when mothers cannot produce enough breast milk and do not cause NEC, a 2024 report stated lack of breast milk, not formula exposure, increases NEC incidence.
18 Articles
18 Articles
Abbott Laboratories to pay $70M in damages in infant formula lawsuit
A Cook County jury has awarded $70 million to four families in their lawsuit against Abbott Laboratories, finding that the company's cow’s-milk-based infant formula contributed to a life-threatening condition in premature infants.Jurors had awarded $53 million in actual damages on Thursday after determining that Illinois-based Abbott’s Similac product caused the infants to develop necrotizing enterocolitis, a severe intestinal disease that prima…
Mason City Globe Gazette
Keller Postman Secures $70 Million in Verdicts for All Four Plaintiffs in Historic Abbott Formula Trial
CHICAGO, April 10, 2026 /PRNewswire/ -- Keller Postman has secured a jury verdict of $70 million for four infants who suffered necrotizing enterocolitis ("NEC") as a result of being fed Similac Special Care. Defendant Abbott Laboratories, which manufactures Similac Special…
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
